Liver Cirrhosis Research - Alcohol, Treatment, Drugs, Effects, Causes

Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.


Liver Cirrhosis Research Today

Home

View Latest Issue

Information About Liver Cirrhosis

Books on Liver Cirrhosis

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 6 (June)

  1. A novel nonsteroidal antifibrotic oligo decoy containing the TGF-beta element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis.
    J Cell Physiol, 204(2): 370-4. [Abstract] [Full-text]
  2. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis.
    J Autoimmun, 24(4): 347-52. [Abstract] [Full-text]
  3. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
    Am J Gastroenterol, 100(6): 1311-6. [Abstract] [Full-text]
  4. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
    Surgery, 137(6): 620-5. [Abstract] [Full-text]
  5. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent.
    Clin Chim Acta, 356(1): 102-9. [Abstract] [Full-text]
  6. Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats.
    Mol Pharm, 2(3): 206-17. [Abstract] [Full-text]
  7. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
    Am J Transplant, 5(7): 1704-12. [Abstract] [Full-text]
  8. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Gut, 54(7): 1003-8. [Abstract] [Full-text]
  9. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
    Gut, 54(7): 987-93. [Abstract] [Full-text]
  10. Expression of apolipoprotein AI mRNA in peripheral white blood cells of patients with alcoholic liver disease.
    Biochim Biophys Acta, 1740(3): 350-6. [Abstract] [Full-text]
  11. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Transpl Int, 18(7): 879-83. [Abstract] [Full-text]
  12. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
    Transpl Int, 18(7): 794-9. [Abstract] [Full-text]
  13. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients.
    Aliment Pharmacol Ther, 21(12): 1459-65. [Abstract] [Full-text]
  14. Gender and liver fibrosis in chronic hepatitis: the role of iron status.
    Aliment Pharmacol Ther, 21(12): 1445-51. [Abstract] [Full-text]
  15. Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation.
    Aliment Pharmacol Ther, 21(12): 1435-43. [Abstract] [Full-text]
  16. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue.
    Ann N Y Acad Sci, 1041: 185-9. [Abstract] [Full-text]
  17. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients.
    J Gastroenterol Hepatol, 20(7): 1115-20. [Abstract] [Full-text]
  18. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
    J Gastroenterol Hepatol, 20(7): 1109-14. [Abstract] [Full-text]
  19. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
    J Gastroenterol Hepatol, 20(7): 1102-8. [Abstract] [Full-text]
  20. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    J Gastroenterol Hepatol, 20(7): 1075-81. [Abstract] [Full-text]
  21. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Clin Pharmacol Ther, 77(6): 529-41. [Abstract] [Full-text]
  22. Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
    Transplant Proc, 37(5): 2207-8. [Abstract] [Full-text]
  23. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure?
    Transplant Proc, 37(5): 2159-62. [Abstract] [Full-text]
  24. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.
    Lab Invest, 85(7): 908-20. [Abstract] [Full-text]
  25. Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
    Mod Pathol, 18(7): 941-50. [Abstract] [Full-text]
  26. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
    Hepatology, 42(1): 27-34. [Abstract] [Full-text]
  27. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
    Hepatology, 42(1): 53-62. [Abstract] [Full-text]
  28. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
    Hepatology, 42(1): 63-71. [Abstract] [Full-text]
  29. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
    Histopathology, 47(1): 57-66. [Abstract] [Full-text]
  30. Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
    J Gene Med, 7(7): 965-76. [Abstract] [Full-text]
  31. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
    Am J Gastroenterol, 100(7): 1523-8. [Abstract] [Full-text]
  32. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy.
    Am J Gastroenterol, 100(7): 1509-15. [Abstract] [Full-text]
  33. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.
    J Magn Reson Imaging, 22(1): 80-5. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.



Liver Cirrhosis Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Liver Cirrhosis Books

The Book of Jesse: A Story of Youth, Illness, and Medicine

The Book of Jesse: A Story of Youth, Illness, and Medicine